import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡å¯¦è­‰åœ–æ›¸é¤¨ (2026 æœ€çµ‚å…¨åŠŸèƒ½æ•´åˆç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    /* === æ¥µè‡´ç·Šç·»åŒ– UI èˆ‡ é«˜å°æ¯”åº¦æ–‡å­— === */
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F4F7F9;
        color: #1A1A1A;
        font-size: 19px !important;
        line-height: 1.1;
    }

    .main-title {
        font-size: 32px !important; font-weight: 900; color: #004D40;
        padding: 5px 0; border-bottom: 3px solid #4DB6AC; margin-bottom: 5px;
    }

    /* å¤§éšæ®µæ–¹å¡Šï¼šé›¶ç•™ç™½è¨­è¨ˆ */
    .big-stage-card {
        border-radius: 10px; padding: 0px; 
        box-shadow: 0 2px 10px rgba(0,0,0,0.08);
        border: 2px solid transparent; background: white; 
        margin-bottom: 4px; overflow: hidden; height: auto !important;
    }
    .big-stage-header {
        font-size: 17px !important; font-weight: 900; color: white;
        padding: 5px; text-align: center;
    }

    /* å­å€å¡Š (SoC èˆ‡åˆ†å­äºå‹) */
    .sub-block {
        margin: 2px 4px; padding: 4px;
        border-radius: 6px; background: #F8F9FA;
        border-left: 5px solid #546E7A;
    }
    .sub-block-title {
        font-size: 13px; font-weight: 900; color: #37474F;
        margin-bottom: 1px; border-bottom: 1.1px solid #CFD8DC; padding-bottom: 1px;
    }
    .sub-block-content {
        font-size: 14px; color: #263238; font-weight: 500; line-height: 1.15;
    }

    /* éšæ®µé…è‰² */
    .card-p-tx { border-color: #2E7D32; }
    .header-p-tx { background: linear-gradient(135deg, #43A047, #2E7D32); }
    .card-p-mt { border-color: #1565C0; }
    .header-p-mt { background: linear-gradient(135deg, #1E88E5, #1565C0); }
    .card-r-tx { border-color: #E65100; }
    .header-r-tx { background: linear-gradient(135deg, #FB8C00, #E65100); }
    .card-r-mt { border-color: #6A1B9A; }
    .header-r-mt { background: linear-gradient(135deg, #8E24AA, #6A1B9A); }

    /* æŒ‰éˆ•æ¨£å¼ï¼šæ·±é»‘è‰²åŠ ç²— (#1A1A1A) */
    .stPopover button { 
        font-weight: 900 !important; font-size: 11px !important; 
        border-radius: 4px !important; margin-top: 1px !important;
        padding: 1px 6px !important; width: 100% !important; 
        text-align: left !important; color: #1A1A1A !important; 
        border: 1px solid rgba(0,0,0,0.15) !important;
        box-shadow: 0 1px 3px rgba(0,0,0,0.1) !important;
    }
    
    .stPopover button[aria-label*="ğŸ“š"] { background: #ECEFF1 !important; border-left: 5px solid #455A64 !important; }
    .stPopover button[aria-label*="ğŸ“"] { background: #E3F2FD !important; border-left: 5px solid #1976D2 !important; } 

    .detail-section { background: white; border-radius: 18px; padding: 25px; border: 1px solid #CFD8DC; box-shadow: 0 10px 40px rgba(0,0,0,0.05); }
    .hr-big-val { font-family: 'Roboto', sans-serif; font-size: 45px !important; font-weight: 900; color: #D84315; }
    </style>
    """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•å°èˆªæ•¸æ“šåº«ï¼šåŒ…å«å…¨ç™Œç—‡éšæ®µã€MOC èˆ‡ PSOC/PROC åˆ†æµ ---
guidelines_nested = {
    "Endometrial": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "MMRd / MSI-H / dMMR", "content": "ä¸€ç·šæ¨™ç«¿ï¼šChemo + PD-1 (GY018/RUBY)ã€‚Dostarlimab ç²ç›Šæ¥µé¡¯è‘—ã€‚"},
            {"title": "NSMP / pMMR / MSS", "content": "æ’é™¤åˆ†å‹ã€‚è¦– ER/Grade æ¬Šé‡æ±ºç­–ï¼›äºŒç·šè€ƒæ…® Pembro+Lenvaã€‚"},
            {"title": "POLEmut / p53abn", "content": "POLE: æœ€ä½³é å¾Œï¼›p53: æœ€å·®é å¾Œï¼Œéœ€ç©æ¥µè¼”åŠ©æ²»ç™‚ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "IO Maintenance", "content": "ä¸€ç·š IO æ²»ç™‚å¾Œæ¥çºŒç¶­æŒç›´åˆ°ç–¾ç—…é€²å±• (PD)ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "Recurrent EC", "content": "äºŒç·šæ–¹æ¡ˆï¼šæ¨™é¶+å…ç–« (pMMR) æˆ– IO å–®è—¥ (MMRd/GARNET)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "ç¶­æŒæœ‰æ•ˆæ²»ç™‚ç›´åˆ°ä¸å¯è€å—æˆ–é€²å±•ã€‚"}]}
    ],
    "Ovarian": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "HGSC / Endometrioid", "content": "æ‰‹è¡“ (PDS/IDS) + Carboplatin/Paclitaxel Â± Bevacizumabã€‚"},
            {"title": "Mucinous (MOC) é‘‘åˆ¥", "content": "åˆ¤å®šï¼šCK7+/SATB2- (åŸç™¼)ã€‚1. Expansile: é å¾Œä½³ã€‚ 2. Infiltrative: é«˜å¾©ç™¼é¢¨éšªï¼Œå»ºè­°ç©æ¥µåŒ–ç™‚ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "BRCA mutated", "content": "Olaparib å–®è—¥ç¶­æŒ 2å¹´ã€‚"}, {"title": "HRD positive (wt)", "content": "Olaparib+Bev (2å¹´) æˆ– Niraparib å–®è—¥ (3å¹´)ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "PSOC (Sensitive Recurrence)", "content": "PFI > 6mã€‚å«é‰‘é›™è—¥ Â± Bevã€‚è©•ä¼°äºŒæ¬¡æ‰‹è¡“ (DESKTOP III)ã€‚"},
            {"title": "PROC (Resistant Recurrence)", "content": "PFI < 6mã€‚å–®è—¥åŒ–ç™‚ Â± Bev æˆ–æ¨™é¶ ADC (MIRASOL/FRAmework)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Platinum Sensitive Maint", "content": "æ•‘æ´ç·©è§£å¾ŒçºŒä»¥ PARPi ç¶­æŒæ²»ç™‚ã€‚"}]}
    ],
    "Cervical": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "CCRT (Locally Advanced)", "content": "åŒæ­¥åŒ–æ”¾ç™‚ã€‚é«˜é¢¨éšªè€…åŒæ­¥ IO (A18) æˆ–èª˜å°åŒ–ç™‚ (INTERLACE)ã€‚"},
            {"title": "Early Stage (Surgery)", "content": "æ ¹æ²»æ€§é–‹è…¹è¡“ (LACC)ã€‚ä½é¢¨éšªè€…é¸å–®ç´”åˆ‡é™¤ (SHAPE)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "Metastatic Maint", "content": "1L è½‰ç§»æ€§ IO æ–¹æ¡ˆå¾Œå»¶çºŒç¶­æŒè‡³é€²å±•ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "Recurr / Metastatic", "content": "ä¸€ç·š Pembro + åŒ–ç™‚ Â± Bevã€‚äºŒç·š ADC (Tivdak) æˆ– IO (EMPOWER)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "ç¶­æŒæœ‰æ•ˆæ²»ç™‚ç›´åˆ°é€²å±•ã€‚"}]}
    ]
}

# --- 2. ç¶œåˆè©¦é©—è³‡æ–™åº« (25 é‡Œç¨‹ç¢‘ + 8 æ‹›å‹Ÿä¸­) ---
all_trials_db = [
    # --- ğŸ“š Published Milestones ---
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H / dMMR"], "name": "ğŸ“š RUBY", "type": "Milestone", "drug": "Dostarlimab + CP", 
     "rationale": "é€é PD-1 é˜»æ–·é‡‹æ”¾å…ç–«åˆ¶å‹•ï¼Œé‡å° MMRd æ—ç¾¤é”åˆ°æŒä¹…æ‡‰ç­”ã€‚",
     "regimen": "Induction: Dostarlimab 500mg Q3W + CP x6 -> Maint: Dostarlimab 1000mg Q6W æœ€é•· 3å¹´ã€‚",
     "inclusion": ["FIGO III-IV æœŸæ™šæœŸæˆ–é¦–æ¬¡å¾©ç™¼ ECã€‚", "åŒ…å« Carcinosarcoma / Serous ç­‰ã€‚"],
     "exclusion": ["å…ˆå‰æ¥å—éç³»çµ±æ€§æŠ—ç™Œæ²»ç™‚ã€‚", "æ´»å‹•æ€§è‡ªé«”å…ç–«ç–¾ç—…ã€‚"],
     "results": "dMMR: HR 0.32; mOS 44.6m (vs 28.2m)."},
    
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H / dMMR", "NSMP / pMMR / MSS"], "name": "ğŸ“š NRG-GY018", "type": "Milestone", "drug": "Pembrolizumab + CP", 
     "regimen": "Pembro 200mg Q3W + CP x6 -> ç¶­æŒ 400mg Q6W æœ€é•· 2å¹´ã€‚",
     "results": "dMMR PFS HR 0.30; pMMR PFS HR 0.54."},

    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["MMRd / MSI-H / dMMR"], "name": "ğŸ“š AtTEnd", "type": "Milestone", "drug": "Atezolizumab + CP", 
     "results": "dMMR PFS HR 0.36; ITT OS HR 0.82 (P=0.048)."},

    {"cancer": "Endometrial", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "name": "ğŸ“š KEYNOTE-775", "type": "Milestone", "drug": "Lenvatinib + Pembro", 
     "results": "pMMR OS HR 0.68; mOS 17.4m vs 12.0m."},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["CCRT (Locally Advanced)"], "name": "ğŸ“š KEYNOTE-A18", "type": "Milestone", "drug": "Pembrolizumab + CCRT", 
     "results": "OS HR 0.67; 36m OS 82.6%."},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["CCRT (Locally Advanced)"], "name": "ğŸ“š CALLA", "type": "Milestone", "drug": "Durvalumab + CCRT", 
     "results": "æ•´é«”é™°æ€§ (HR 0.84)ã€‚æé†’éœ€æ›´ç²¾æº–åˆ†æµã€‚"},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š KEYNOTE-826", "type": "Milestone", "drug": "Pembro + åŒ–ç™‚ Â± Bev", 
     "results": "OS HR 0.63 (ITT); HR 0.60 (CPSâ‰¥1)."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š BEATcc", "type": "Milestone", "drug": "Atezo + Chemo + Bev", 
     "results": "PFS HR 0.62; OS HR 0.68."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š EMPOWER-Cx 1", "type": "Milestone", "drug": "Cemiplimab", 
     "results": "OS HR 0.69; mOS 12.0m vs 8.5m."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š innovaTV 301", "type": "Milestone", "drug": "Tisotumab Vedotin", 
     "results": "OS 11.5m vs 9.5m (HR 0.70); ORR 17.8%."},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Early Stage (Surgery)"], "name": "ğŸ“š SHAPE trial", "type": "Milestone", "drug": "Simple Hysterectomy", 
     "results": "3yr Pelvic Recurrence: 2.5% vs 2.2%. æ”¯æŒé™éšã€‚"},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive (wt)"], "name": "ğŸ“š PAOLA-1", "type": "Milestone", "drug": "Olaparib + Bevacizumab", 
     "results": "HRD+ OS HR 0.62; 5yr OS 75.2%."},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["BRCA mutated", "HRD positive (wt)"], "name": "ğŸ“š ATHENAâ€“MONO", "type": "Milestone", "drug": "Rucaparib", 
     "results": "ITT PFS HR 0.52 (28.7m vs 11.3m)."},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š NOVA", "type": "Milestone", "drug": "Niraparib ç¶­æŒ", 
     "results": "gBRCA HR 0.27; Non-gBRCA HR 0.45."},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š ARIEL3", "type": "Milestone", "drug": "Rucaparib ç¶­æŒ", 
     "results": "BRCAm HR 0.23; HRD+ HR 0.32."},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š SOLO2", "type": "Milestone", "drug": "Olaparib (BRCA)", 
     "results": "mOS 51.7m vs 38.8m; HR 0.74."},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive (wt)"], "name": "ğŸ“š DUO-O", "type": "Milestone", "drug": "Durva+Ola+Bev", 
     "results": "HRD+ PFS HR 0.49."},

    {"cancer": "Ovarian", "pos": "P-TX", "sub_pos": ["HGSC / Endometrioid"], "name": "ğŸ“š LION (NEJM 2019)", "type": "Milestone", "drug": "No Lymphadenectomy", 
     "results": "OS HR 1.06. æ”¯æŒ LN é™°æ€§å…æ¸…æƒã€‚"},

    # --- ğŸ“ Ongoing Trials ---
    {"cancer": "Ovarian", "name": "ğŸ“ FRAmework-01 (LY4170156)", "pharma": "Eli Lilly", "drug": "LY4170156 + Bevacizumab", "pos": "R-TX", "sub_pos": ["PROC (Resistant Recurrence)"], "type": "Ongoing",
     "rationale": "æ¨™é¶ FRÎ± ADCã€‚è¯ç”¨ Bevacizumab æå‡è—¥ç‰©æ»²é€ä¸¦é€éæ—è§€è€…æ•ˆæ‡‰æ®ºå‚·ä½è¡¨é”ç´°èƒã€‚",
     "regimen": "LY4170156 3mg/kg IV + Bevacizumab 15mg/kg IV Q3Wã€‚",
     "inclusion": ["ä¸­å¤®å¯¦é©—å®¤ç¢ºèª FRÎ± è¡¨é”é™½æ€§ã€‚", "æœ€å¾Œä¸€åŠ‘é‰‘é¡å¾Œ 90â€“180 å¤©å…§æƒ¡åŒ– (PROC)ã€‚"],
     "exclusion": ["æ›¾ç”¨é Topo I ADC (Enhertu)ã€‚", "æ´»å‹•æ€§é–“è³ªæ€§è‚ºç—… (ILD)ã€‚"], "results": "Ongoing (NCT06536348)."},

    {"cancer": "Ovarian", "name": "ğŸ“ REJOICE-Ovarian01", "pharma": "Daiichi Sankyo", "drug": "R-DXd", "pos": "R-TX", "sub_pos": ["PROC (Resistant Recurrence)"], "type": "Ongoing",
     "rationale": "æ¨™é¶ Cadherin-6 (CDH6) ADCï¼Œå…·å¼·åŠ›æ—è§€è€…æ•ˆæ‡‰ï¼Œå°ˆæ”»ç•°è³ªæ€§ PROCã€‚",
     "regimen": "R-DXd 5.6mg/kg IV Q3Wã€‚",
     "inclusion": ["HG Serous æˆ– Endometrioid PROCã€‚", "æä¾›åˆ‡ç‰‡é€²è¡Œ CDH6 åˆ†å±¤åˆ¤å®šã€‚"],
     "exclusion": ["Low-grade è…«ç˜¤ã€‚", "LVEF < 50%ã€‚"], "results": "Phase 3 recruitment ongoing."},

    {"cancer": "Ovarian", "name": "ğŸ“ TroFuse-021", "pharma": "MSD", "drug": "Sac-TMT (MK-2870)", "pos": "P-MT", "sub_pos": ["HRD positive (wt)", "HRD negative / pHRD"], "type": "Ongoing",
     "rationale": "æ¨™é¶ Trop-2 ADCã€‚çµåˆ Beva å¾®ç’°å¢ƒèª¿ç¯€ï¼Œå„ªåŒ–ç¶­æŒç²ç›Šã€‚",
     "regimen": "Sac-TMT 5mg/kg Q3W + Bevacizumab 15mg/kg Q3Wã€‚",
     "inclusion": ["æ–°è¨ºæ–· FIGO Stage III/IV åµå·¢ç™Œã€‚", "ä¸€ç·šå«é‰‘åŒ–ç™‚å¾Œé” CR æˆ– PRã€‚"],
     "exclusion": ["BRCA è®Šç•°è€…ã€‚", "å…ˆå‰ç”¨é Trop-2 ADCã€‚"], "results": "Phase 3 ongoing."},

    {"cancer": "Endometrial", "name": "ğŸ“ MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembrolizumab", "pos": "P-MT", "sub_pos": ["IO Maintenance"], "type": "Ongoing",
     "rationale": "æ¨™é¶ Trop-2 ADC å”åŒ PD-1ã€‚é€éå…ç–«é‡å¡‘æå‡ Pembro åœ¨ pMMR æ—ç¾¤æ‡‰ç­”ã€‚",
     "regimen": "Pembro 400mg Q6W + Sac-TMT 5mg/kg Q6Wã€‚",
     "inclusion": ["pMMR å­å®®å…§è†œç™Œ (ä¸­å¿ƒæª¢æ¸¬)ã€‚", "FIGO III/IV ä¸€ç·šå«é‰‘+Pembroå¾Œé” CR/PRã€‚"],
     "exclusion": ["å­å®®è‚‰ç˜¤ (Sarcoma)ã€‚"], "results": "Phase 3 recruiting."},
]

# --- 4. å‹•æ…‹æ¨¡å‹å·¡é‚èˆ‡ AI ä¿®å¾© ---
def get_gemini_model():
    try:
        available_models = [m.name for m in genai.list_models() if 'generateContent' in m.supported_generation_methods]
        target_model = None
        for m in available_models:
            if 'gemini-1.5-flash' in m: target_model = m; break
        if not target_model:
            for m in available_models:
                if 'gemini-pro' in m or 'gemini-1.5-pro' in m: target_model = m; break
        if target_model: return genai.GenerativeModel(target_model)
    except: return None

# --- 5. å´é‚Šæ¬„ ---
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = all_trials_db[0]['name']

with st.sidebar:
    st.markdown("<h3 style='color: #6A1B9A;'>ğŸ¤– AI å¯¦è­‰æ±ºç­–åŠ©ç†</h3>", unsafe_allow_html=True)
    api_key = st.text_input("Gemini API Key", type="password")
    with st.expander("âœ¨ ç—…æ­·æ•¸æ“šæ¯”å°", expanded=True):
        p_notes = st.text_area("è¼¸å…¥ç—…æ­· (ç´°èƒå‹æ…‹/æ¨™è¨˜)", height=250)
        if st.button("ğŸš€ é–‹å§‹åˆ†æ"):
            if api_key and p_notes:
                try:
                    genai.configure(api_key=api_key)
                    model = get_gemini_model()
                    if model:
                        prompt = f"åˆ†æç—…æ­·ï¼š{p_notes}ã€‚åƒè€ƒå¯¦è­‰ï¼š{all_trials_db}ã€‚å»ºè­°é©åˆè·¯å¾‘èˆ‡ç†ç”±ã€‚"
                        st.write(model.generate_content(prompt).text)
                    else: st.error("æ‰¾ä¸åˆ°å¯ç”¨ AIã€‚")
                except Exception as e: st.error(f"AI ç•°å¸¸: {e}")

# --- 6. ä¸»é é¢ï¼šå°èˆªåœ°åœ– ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠå°èˆªå„€è¡¨æ¿ (2026 å¯¦è­‰èˆ‡æ”¶æ¡ˆæ•´åˆç‰ˆ)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)

cols = st.columns(len(guidelines_nested[cancer_type]))
stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
    with cols[i]:
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
            
            # é¡¯ç¤ºè©²å€å¡Šå°æ‡‰çš„æ‰€æœ‰è©¦é©— (ğŸ“š & ğŸ“)
            rel_trials = [t for t in all_trials_db if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
            for t in rel_trials:
                label = t["name"] if t["type"] == "Milestone" else t["name"]
                with st.popover(label, use_container_width=True):
                    st.success(f"**ä»‹å…¥:** {t['drug']}\n\n**çµè«–æ‘˜è¦:** {t.get('results', 'è©³è¦‹å ±å‘Š')}")
                    if st.button("ğŸ“Š åŒæ­¥çœ‹æ¿ç´°ç¯€", key=f"sync_{t['name']}_{stage['id']}"):
                        st.session_state.selected_trial = t['name']
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- 7. è‡¨åºŠè©¦é©—æ·±åº¦æ•¸æ“šåº« (é¸æ“‡å™¨èˆ‡æ¸…å–®) ---
st.divider()
st.subheader("ğŸ“‹ è‡¨åºŠç ”ç©¶æ·±åº¦æ•¸æ“šåº« (Published Milestones & Ongoing Trials)")
filtered_list = [t for t in all_trials_db if t["cancer"] == cancer_type]
selected_name = st.selectbox("ğŸ¯ å¿«é€Ÿé»é¸ç ”ç©¶è¨ˆç•«ï¼š", [t["name"] for t in filtered_list], key="trial_selector")

# åŒæ­¥é¸ä¸­çš„è¨ˆç•«æ•¸æ“š
t = next(it for it in all_trials_db if it["name"] == selected_name)

st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:10px; font-weight:900;'>ğŸ“‹ {t['name']} æ·±åº¦åˆ†æå ±å‘Š</h2>", unsafe_allow_html=True)

r1, r2 = st.columns([1.3, 1])
with r1:
    st.markdown("<div style='background:#E3F2FD; border-left:10px solid #1976D2; padding:15px; border-radius:10px;'><b>ğŸ’‰ Rationale & Regimen (æ©Ÿè½‰èˆ‡çµ¦è—¥)</b></div>", unsafe_allow_html=True)
    st.write(f"**æ ¸å¿ƒè—¥ç‰©/æ–¹æ¡ˆ:** {t['drug']}")
    st.write(f"**è©³ç´°çµ¦è—¥:** {t.get('regimen', t.get('dosing', 'è©³è¦‹æ‹›å‹Ÿç´°å‰‡'))}")
    st.success(t.get('rationale', 'è©²ç ”ç©¶æ©Ÿè½‰ä¸»è¦é€éå‰æ²¿æ¨™é¶æˆ–å…ç–«èª¿ç¯€æŒ‘æˆ°ç¾æœ‰ SoCã€‚'))
    

with r2:
    st.markdown("<div style='background:#FFF8E1; border-left:8px solid #FBC02D; padding:15px; border-radius:10px;'><b>ğŸ“ˆ Key Evidence (ç”Ÿå­˜èˆ‡ç·©è§£æ•¸æ“š)</b></div>", unsafe_allow_html=True)
    st.markdown(f"""
        <div style='text-align:center; background:white; padding:15px; border:2px solid #FFE082; border-radius:12px;'>
            <div style='font-size: 14px; color: #795548; font-weight:700; margin-bottom:5px;'>Survival Metrics (PFS/OS/HR)</div>
            <div class='hr-big-val'>{t.get('results', 'Recruiting...')}</div>
        </div>
    """, unsafe_allow_html=True)
    

st.divider()
r3, r4 = st.columns(2)
with r3:
    st.markdown("<div style='background:#E8F5E9; border-left:8px solid #2E7D32; padding:15px; border-radius:10px;'><b>âœ… Inclusion Criteria (ç´å…¥æ¢ä»¶)</b></div>", unsafe_allow_html=True)
    for inc in t.get('inclusion', ['è©³è¦‹å…¨æ–‡ Protocolã€‚']): st.write(f"â€¢ **{inc}**")
with r4:
    st.markdown("<div style='background:#FFEBEE; border-left:8px solid #C62828; padding:15px; border-radius:10px;'><b>âŒ Exclusion Criteria (æ’é™¤æ¨™æº–)</b></div>", unsafe_allow_html=True)
    for exc in t.get('exclusion', ['è©³è¦‹å…¨æ–‡ Protocolã€‚']): st.write(f"â€¢ **{exc}**")
st.markdown("</div>", unsafe_allow_html=True)
